LLY
ELI LILLY & Co
NYSE · Healthcare · Drug Manufacturers - General · US
$1,414.27
+0.35%Leverage
- Debt / equity
- 1.23x
- Net debt / equity
- 1.11x
- Debt / assets
- 0.33x
- Debt / EBITDA
- 1.11x
- Net debt / EBITDA
- 1.00x
Liquidity & coverage
- Current ratio
- 1.39x
- Quick ratio
- 1.00x
- Cash ratio
- 0.10x
- Interest coverage
- 33.81x
- EBITDA / interest
- 37.99x
- Working capital
- $18.3B
Cash & dividend
- FCF / debt
- 0.40x
- Cash flow / debt
- 0.62x
- Dividend per share
- $6.69
- Dividend yield
- 0.5%
- Dividend growth 1y
- +15.4%
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Sep 1, 2026